查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498771

个人化医疗生物标记市场，按适应症、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Personalized Medicine Biomarkers Market, By Indication, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 270 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年个人化医疗生物标记市场规模为149.0834亿美元，2024年至2032年复合年增长率为14.30%。

个人化医疗生物标记市场-市场动态

由于慢性病盛行率的上升以及人们对预后预测重要性的日益认识，预计该市场将出现成长

癌症、心血管疾病、糖尿病和神经退化性疾病等慢性疾病在全球范围内不断增加。客製化医学为这些疾病提供精确有效的治疗方案，通常利用生物标记为个别患者量身订做治疗方案。根据美国国家卫生统计中心的数据，慢性病是指持续三个月或更长的疾病。由于一种或多种慢性健康问题，大约 4000 万美国人的日常活动受到限制。预后生物标记有助于预测疾病结果，促进临床环境中做出更明智的决策。此外，政府和私营部门对个人化医疗研究的加大投资支持了新生物标记和诊断工具的进步，为市场创造了成长机会。然而，与监管和报销相关的挑战可能会阻碍市场的扩张。

个人化医疗生物标记市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 14.30% 左右的复合年增长率成长

根据适应症细分，肿瘤学预计将在 2023 年显示最大的市场份额

基于应用细分，2023年早期检测/筛检为主导类型

按地区划分，北美是 2023 年的主要收入来源

个人化医疗生物标记市场-細項分析：

全球个人化医疗生物标记市场根据适应症、应用、最终用户和地区进行细分。

根据适应症，市场分为三个部分：神经病学、肿瘤学、糖尿病、心臟病学、自体免疫疾病和其他。该市场主要由肿瘤学领域主导。由于技术进步和对客製化治疗方法的需求不断增长，个人化医疗生物标记市场，特别是在肿瘤学领域，正在大幅增长。

根据应用，市场分为两个部分：诊断、治疗选择、早期检测/筛检和监测。市场的主导部分是早期检测/筛检。早期检测和筛检生物标记的重要性怎么强调都不为过，因为它们有助于在更早、更易于管理的阶段识别疾病，从而改善患者的治疗效果并降低医疗费用。

根据最终用户，市场分为两个不同的类别：医院和诊所以及其他实体。医院、诊所和诊断实验室仍将是重要的最终用户，利用生物标记来提高诊断精度和治疗效果。

个人化医疗生物标记市场 - 地理洞察

从地理上看，该市场横跨北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据对商业活动有贡献的国家进一步细分。在个人化医疗需求不断增长的推动下，该市场主要由北美主导。由于需要更有效和客製化的治疗方案，北美特别关注个人化医疗。个人化医疗致力于个人化医疗保健，为每位患者量身订做医疗决策和治疗方案。根据《美国管理医疗杂誌》报道，2016 年至 2020 年整体成长显着，市场上的个人化药物数量从 132 种增加到 286 种。采用率不断上升，欧洲成为第二大市场成长地区。

个人化医疗生物标记市场-竞争格局：

个人化医疗生物标记市场的竞争格局表现为各主要参与者之间的激烈竞争。这些公司正在研发方面进行大量投资，以发现新的生物标记并创建先进的诊断测试。这种持续的创新对于维持市场领先地位至关重要。基因组学、蛋白质组学和生物资讯学的快速发展正在推动市场向前发展。有效利用这些技术的公司可以获得竞争优势。在这个竞争激烈的市场中，主要参与者都在努力透过策略性措施进行创新并扩大其能力。持续的技术进步、策略合作以及注重获得监管批准对于公司维持和加强其市场地位至关重要。

最近的发展：

2024 年 2 月 12 日星期一，雅培 (Abbott) 和 Fujirebio 宣布建立合作伙伴关係，合作开发仅供研究使用的神经丝轻链 (NfL) 测试。两家公司在联合声明中透露，这种神经学生物标记检测将与 Abbott 的 Alinity I 仪器相容，并将可供从事证明 NfL 生物标记有效性研究的研究人员使用。目标是到 2025 年使该测试商业化，使其成为 Alinity I 系统的首次 RUO 检测。

总部位于比利时梅赫伦的 Biocartis 公司最近宣布与默克雪兰诺中东公司和默克沙特有限公司（默克集团在 MEA 地区的子公司）扩大联盟。此次合作的主要目的是提高中东和北非患者进行 RAS 生物标记检测的可近性。

目录

第 1 章：个人化医疗生物标记市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 个人化医疗生物标记市场片段（按适应症）
    • 个人化医疗生物标记市场片段（按应用）
    • 最终用户的个人化医疗生物标记市场片段
    • 按国家/地区分類的个人化医疗生物标记市场片段
    • 按地区分類的个人化医疗生物标记市场片段
  • 竞争洞察

第 3 章：个人化医疗生物标记主要市场趋势

  • 个人化医疗生物标记市场驱动因素
    • 市场驱动因素的影响分析
  • 个人化医疗生物标记市场限制
    • 市场限制影响分析
  • 个人化医疗生物标记市场机会
  • 个人化医疗生物标记市场未来趋势

第 4 章：个人化医疗生物标记产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：个人化医疗生物标记市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：个人化医疗生物标记市场格局

  • 个人化医疗生物标记市场份额分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：个人化医疗生物标记市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 肿瘤学
    • 神经病学
    • 糖尿病
    • 自体免疫疾病
    • 心臟病学
    • 其他的

第 8 章：个人化医疗生物标记市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 早期检测/筛检
    • 诊断
    • 治疗选择
    • 监控

第 9 章：个人化医疗生物标记市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 其他的

第 10 章：个人化医疗生物标记市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 个性化医疗生物标誌物北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 个性化医疗生物标记欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区个人化医疗生物标记主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 个性化医疗生物标誌物拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 个性化医疗生物标记中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 个人化医疗生物标记产业

  • 竞争仪表板
  • 公司简介
    • Siemens Healthineers
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Nexus-DX
    • Qiagen
    • PerkinElmer Inc.
    • Lifesign LLC
    • Merck & Co Inc.
    • Bio-Rad Laboratories, Inc.
    • EKF Diagnostics Holdings plc
    • Singulex Inc.
    • Signosis Inc.
    • BioSims Technologies
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Illumina Inc.
    • Myriad Genetics, Inc.
    • Biomarker Technologies, Inc.
    • Danaher Corporation
    • Epigenomics AG
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2942

REPORT HIGHLIGHT

Personalized Medicine Biomarkers Market size was valued at USD 14,908.34 million in 2023, expanding at a CAGR of 14.30% from 2024 to 2032.

Personalized medicine, involving the use of biomarkers in clinical samples, is a fascinating field with important implications for drug development. Biomarkers act as measurable indicators of a biological state or condition, allowing for the prediction of disease risk, diagnosis of conditions, monitoring of disease progression, and guidance of treatment decisions. They are essential in personalized medicine, offering possibilities to improve patient outcomes through precise and individualized healthcare. Continuous progress in biomarker research and technology is driving the field ahead, leading to a future where treatments are tailored more and more to each patient's unique traits.

Personalized Medicine Biomarkers Market- Market Dynamics

The market is anticipated to experience growth due to the rising prevalence of chronic diseases and the increasing recognition of the significance of prognostic prediction

Chronic illnesses, such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders, are increasing on a global scale. Tailored medicine provides precise and efficient treatment options for these ailments, often utilizing biomarkers to customize therapies for individual patients. According to the U.S. National Center for Health Statistics, a chronic illness is a condition that persists for three months or longer. Approximately 40 million Americans face limitations in their daily activities due to one or more chronic health issues. Prognostic biomarkers aid in forecasting disease outcomes, facilitating more informed decision-making in clinical settings. Moreover, the heightened investment in personalized medicine research by both governmental and private sectors supports the advancement of new biomarkers and diagnostic tools, creating growth opportunities for the market. Nevertheless, challenges related to regulations and reimbursement may impede the market's expansion.

Personalized Medicine Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.30% over the forecast period (2024-2032)

Based on Indication segmentation, Oncology was predicted to show maximum market share in the year 2023

Based on application segmentation, Early Detection/Screening was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Personalized Medicine Biomarkers Market- Segmentation Analysis:

The Global Personalized Medicine Biomarkers Market is segmented based on Indication, Application, End-User, and Region.

The market is categorized into three segments based on Indication: Neurology, Oncology, Diabetes, Cardiology, Autoimmune Diseases, and Others. The market is primarily dominated by the Oncology segment. The personalized medicine biomarkers market, particularly in the field of oncology, is witnessing substantial growth owing to technological advancements and a rising need for customized treatment methods.

The market is categorized into two segments according to their application: Diagnosis, Treatment Selection, Early Detection/Screening, and Monitoring. The dominant segment in the market is Early Detection/Screening. The significance of early detection and screening biomarkers cannot be overstated as they facilitate the identification of diseases at an earlier and more manageable stage, leading to better patient outcomes and decreased healthcare expenses.

The market is segmented into two distinct categories based on the end-user: hospitals and clinics, and other entities. Hospitals, clinics, and diagnostic laboratories will remain crucial end-users, utilizing biomarkers to improve diagnostic precision and treatment effectiveness.

Personalized Medicine Biomarkers Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is predominantly led by North America, driven by the increasing demand for personalized medicine. There is a notable focus on personalized medicine in North America, spurred by the necessity for more efficient and customized treatment options. Personalized medicine strives to individualize healthcare, tailoring medical decisions and treatments to each patient. As per the American Journal of Managed Care, there has been significant growth overall from 2016 to 2020, with the number of personalized medicines in the market increasing from 132 to 286. These medicines represented 25% of the new drugs approved by the FDA in 2019. Europe follows as the second largest region for market growth, attributed to the rising adoption of Companion Diagnostics.

Personalized Medicine Biomarkers Market- Competitive Landscape:

The competitive landscape of the personalized medicine biomarkers market is characterized by fierce competition among various key players. These companies are making significant investments in research and development to discover new biomarkers and create advanced diagnostic tests. This constant innovation is crucial to stay ahead in the market. The market is being driven forward by rapid advancements in genomics, proteomics, and bioinformatics. Companies that effectively utilize these technologies can gain a competitive edge. In this highly competitive market, major players are striving to innovate and expand their capabilities through strategic initiatives. Continuous technological advancements, strategic collaborations, and a focus on obtaining regulatory approvals are vital for companies to maintain and strengthen their positions in the market.

Recent Developments:

On Monday, February 12, 2024, Abbott and Fujirebio announced their partnership to collaborate on the development of a research-use-only test for the neurofilament-light chain (NfL). In a joint statement, the companies revealed that this neurology biomarker assay will be compatible with Abbott's Alinity I instrument and will be made accessible to researchers engaged in studies that demonstrate the effectiveness of the NfL biomarker. The objective is to make this test commercially available by 2025, marking it as the inaugural RUO assay for the Alinity I system.

Biocartis, a Mechelen-based company in Belgium, has recently revealed an expanded alliance with Merck Serono Middle East and Merck Saudi Ltd., both subsidiaries of Merck KGaA, in the MEA region. The main aim of this partnership is to improve the accessibility of RAS biomarker testing for patients in the Middle East and North Africa.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Siemens Healthineers

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Nexus-DX

Qiagen

PerkinElmer Inc.

Lifesign LLC

Merck & Co Inc.

Bio-Rad Laboratories, Inc.

EKF Diagnostics Holdings plc

Singulex Inc.

Signosis Inc.

BioSims Technologies

Agilent Technologies, Inc.

Thermo Fisher Scientific, Inc.

Illumina Inc.

Myriad Genetics, Inc.

Biomarker Technologies, Inc.

Danaher Corporation

Epigenomics AG

Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Diabetes
  • Autoimmune Diseases
  • Cardiology
  • Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Early Detection/Screening
  • Diagnosis
  • Treatment Selection
  • Monitoring

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and clinics
  • Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Personalized Medicine Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Personalized Medicine Biomarkers Market Snippet by Indication
    • 2.1.2. Personalized Medicine Biomarkers Market Snippet by Application
    • 2.1.3. Personalized Medicine Biomarkers Market Snippet by End-User
    • 2.1.4. Personalized Medicine Biomarkers Market Snippet by Country
    • 2.1.5. Personalized Medicine Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. Personalized Medicine Biomarkers Key Market Trends

  • 3.1. Personalized Medicine Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Personalized Medicine Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Personalized Medicine Biomarkers Market Opportunities
  • 3.4. Personalized Medicine Biomarkers Market Future Trends

4. Personalized Medicine Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Personalized Medicine Biomarkers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Personalized Medicine Biomarkers Market Landscape

  • 6.1. Personalized Medicine Biomarkers Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Personalized Medicine Biomarkers Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 7.1.2. Oncology
    • 7.1.3. Neurology
    • 7.1.4. Diabetes
    • 7.1.5. Autoimmune Diseases
    • 7.1.6. Cardiology
    • 7.1.7. Others

8. Personalized Medicine Biomarkers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Early Detection/Screening
    • 8.1.3. Diagnosis
    • 8.1.4. Treatment Selection
    • 8.1.5. Monitoring

9. Personalized Medicine Biomarkers Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and clinics
    • 9.1.3. Others

10. Personalized Medicine Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Personalized Medicine Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Personalized Medicine Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Personalized Medicine Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Personalized Medicine Biomarkers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Personalized Medicine Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Personalized Medicine Biomarkers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Siemens Healthineers
    • 11.2.2. F. Hoffmann-La Roche Ltd
    • 11.2.3. Abbott Laboratories
    • 11.2.4. Nexus-DX
    • 11.2.5. Qiagen
    • 11.2.6. PerkinElmer Inc.
    • 11.2.7. Lifesign LLC
    • 11.2.8. Merck & Co Inc.
    • 11.2.9. Bio-Rad Laboratories, Inc.
    • 11.2.10. EKF Diagnostics Holdings plc
    • 11.2.11. Singulex Inc.
    • 11.2.12. Signosis Inc.
    • 11.2.13. BioSims Technologies
    • 11.2.14. Agilent Technologies, Inc.
    • 11.2.15. Thermo Fisher Scientific, Inc.
    • 11.2.16. Illumina Inc.
    • 11.2.17. Myriad Genetics, Inc.
    • 11.2.18. Biomarker Technologies, Inc.
    • 11.2.19. Danaher Corporation
    • 11.2.20. Epigenomics AG
    • 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Personalized Medicine Biomarkers Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Personalized Medicine Biomarkers Market, by Indication 2019-2032 (USD Million)
  • TABLE Personalized Medicine Biomarkers Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Personalized Medicine Biomarkers Market, by Application 2019-2032 (USD Million)
  • TABLE Personalized Medicine Biomarkers Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Personalized Medicine Biomarkers Market, by End-User 2019-2032 (USD Million)
  • TABLE Personalized Medicine Biomarkers Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Personalized Medicine Biomarkers Market, by Region 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)